

Kelly Morrison
U.S. Representative (D) for Minnesota, 57 years old, formerly physician.
- physician
- B.A. Yale University (1991)
- M.D. Case Western Reserve University (1997)
MORRISON, Kelly, a Representative from Minnesota; born in Minneapolis, Hennepin County, Minn., February 2, 1969; graduated from The Blake School, Minneapolis, Minn., 1987; B.A., Yale University, New Haven, Conn., 1991; attended Boston University, Boston, Mass.; M.D., Case Western Reserve University, Cleveland, Ohio, 1997; physician; member of the Minnesota state house of representatives, 2019-2023; member of the Minnesota state senate, 2023-2024; elected as a Democrat to the One Hundred Nineteenth Congress (January 3, 2025-present).
Source: U.S. Congress Bioguide / public-record corporate filings.
Track record by window
Disclosed trades · 66
All filings →| Filed | Trade date | Type | Stock | Smart move? | Size |
|---|---|---|---|---|---|
| Mar 10, 2026 | Mar 8, 2026 2 days to disclose | ↓sold | M MICCN.V. Ordinary Shares (MICC) | Flat·+0.0% +10.7% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Mar 10, 2026 | Mar 8, 2026 2 days to disclose | ↓sold | M MICCN.V. Ordinary Shares (MICC) | Flat·+0.0% +10.7% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Mar 10, 2026 | Mar 8, 2026 2 days to disclose | ↓sold | Stock (AJG) | Flat·+0.0% +3.0% vs S&P 500 | $15K-$50K $15,001 - $50,000 3.1% of book |
| Mar 10, 2026 | Mar 8, 2026 2 days to disclose | ↓sold | Stock (AJG) | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Mar 10, 2026 | Mar 8, 2026 2 days to disclose | ↓sold | Stock (AJG) Trust 8 Saronic Technologies [OI] P 03/09/2026 03/09/2026 $15,001 - $50,000 | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jan 20, 2026 | Dec 10, 2025 41 days to disclose | ↔exchanged | A ASHGYASHTED GRP PLC S/ADR (ASHGY) | price pending | $15K-$50K $15,001 - $50,000 3.1% of book |
| Jan 20, 2026 | Dec 10, 2025 41 days to disclose | ↔exchanged | A ASHGYASHTED GRP PLC S/ADR (ASHGY) | price pending | $15K-$50K $15,001 - $50,000 3.1% of book |
| Jan 20, 2026 | Dec 10, 2025 41 days to disclose | ↔exchanged | A ASHGYASHTED GRP PLC S/ADR (ASHGY) | price pending | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jan 20, 2026 | Dec 10, 2025 41 days to disclose | ↔exchanged | A ASHGYASHTED GRP PLC S/ADR (ASHGY) | price pending | $1K-$15K $1,001 - $15,000 0.8% of book |
| Sep 11, 2025 | Aug 19, 2025 23 days to disclose | ↓sold | Accenture plc Class A Ordinary Shares (ACN) | Flat·+0.0% +41.5% vs S&P 500 | $15K-$50K $15,001 - $50,000 3.1% of book |
| Sep 11, 2025 | Aug 19, 2025 23 days to disclose | ↓sold | Accenture plc Class A Ordinary Shares (ACN) | Flat·+0.0% +41.5% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Sep 11, 2025 | Aug 19, 2025 23 days to disclose | ↓sold | Accenture plc Class A Ordinary Shares (ACN) | Flat·+0.0% +41.5% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Sep 11, 2025 | Aug 19, 2025 23 days to disclose | ↓sold | Accenture plc Class A Ordinary Shares (ACN) | Flat·+0.0% +41.5% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Sep 11, 2025 | Aug 19, 2025 23 days to disclose | ↓sold | Stock (TMO) ⚑ Healthcare · Committee on Veterans' Affairs | Flat·+0.0% +8.6% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Sep 11, 2025 | Aug 19, 2025 23 days to disclose | ↓sold | Stock (TMO) ⚑ Healthcare · Committee on Veterans' Affairs | Flat·+0.0% +8.6% vs S&P 500 | $15K-$50K $15,001 - $50,000 3.1% of book |
| Sep 11, 2025 | Aug 19, 2025 23 days to disclose | ↓sold | Stock (TMO) ⚑ Healthcare · Committee on Veterans' Affairs | Flat·+0.0% +8.6% vs S&P 500 | $15K-$50K $15,001 - $50,000 3.1% of book |
| Sep 11, 2025 | Aug 19, 2025 23 days to disclose | ↓sold | Stock (TMO) ⚑ Healthcare · Committee on Veterans' Affairs | Flat·+0.0% +8.6% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Sep 11, 2025 | Aug 19, 2025 23 days to disclose | ↓sold | Common Stock (VZ) Trust 2 | Flat·+0.0% +4.9% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Sep 11, 2025 | Aug 19, 2025 23 days to disclose | ↓sold | Johnson & Johnson Common Stock (JNJ) ⚑ Pharmaceutical · Health | Flat·+0.0% +8.6% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Sep 11, 2025 | Aug 19, 2025 23 days to disclose | ↓sold | Accenture plc Class A Ordinary Shares (ACN) | Flat·+0.0% +41.5% vs S&P 500 | $15K-$50K $15,001 - $50,000 3.1% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | Z ZBRAClass A Common Stock (ZBRA) | Flat·+0.0% +56.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | Z ZBRAClass A Common Stock (ZBRA) | Flat·+0.0% +56.4% vs S&P 500 | $15K-$50K $15,001 - $50,000 3.1% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | W WEXWEX Inc. common stock (WEX) Trust 3 | Flat·+0.0% +26.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | Z ZBRAClass A Common Stock (ZBRA) | Flat·+0.0% +56.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | W WEXWEX Inc. common stock (WEX) | Flat·+0.0% +26.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | W WEXWEX Inc. common stock (WEX) | Flat·+0.0% +26.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | H HLICommon Stock (HLI) | Flat·+0.0% +2.1% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | Nike, Inc. Common Stock (NKE) | Flat·+0.0% +11.2% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | Nike, Inc. Common Stock (NKE) | Flat·+0.0% +11.2% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | R RMDResMed Inc. Common Stock (RMD) ⚑ Healthcare · Committee on Veterans' Affairs | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | R RMDResMed Inc. Common Stock (RMD) ⚑ Healthcare · Committee on Veterans' Affairs | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | R RMDResMed Inc. Common Stock (RMD) ⚑ Healthcare · Committee on Veterans' Affairs | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | Common Stock (UPS) | Flat·+0.0% +21.2% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | Common Stock (UPS) | Flat·+0.0% +21.2% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | Z ZBRAClass A Common Stock (ZBRA) Trust 4 | Flat·+0.0% +56.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | Common Stock (UPS) | Flat·+0.0% +21.2% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Jun 18, 2025 | Jun 4, 2025 14 days to disclose | ↓sold | R RMDResMed Inc. Common Stock (RMD) ⚑ Healthcare · Committee on Veterans' Affairs | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| May 13, 2025 | Apr 28, 2025 15 days to disclose | ↓sold | R RMDResMed Inc. Common Stock (RMD) Trust 1 ⚑ Healthcare · Committee on Veterans' Affairs | Flat·+0.0% +7.2% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| May 13, 2025 | Apr 11, 2025 32 days to disclose | ↑bought | Common Stock (META) | Good buy·+$796+9.9% −76.7% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| May 13, 2025 | Apr 11, 2025 32 days to disclose | ↑bought | (AVGO) | Good buy·+$53.8K+165.5% +78.8% vs S&P 500 | $15K-$50K $15,001 - $50,000 3.1% of book |
| May 13, 2025 | Apr 11, 2025 32 days to disclose | ↑bought | (AVGO) | Good buy·+$13.2K+165.5% +78.8% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| May 13, 2025 | Apr 11, 2025 32 days to disclose | ↑bought | Common Stock (META) | Good buy·+$3.2K+9.9% −76.7% vs S&P 500 | $15K-$50K $15,001 - $50,000 3.1% of book |
| May 13, 2025 | Apr 10, 2025 33 days to disclose | ↓sold | A ASHTY(ASHTY) | price pending | $1K-$15K $1,001 - $15,000 0.8% of book |
| May 13, 2025 | Apr 10, 2025 33 days to disclose | ↓sold | A ASHTY(ASHTY) | price pending | $1K-$15K $1,001 - $15,000 0.8% of book |
| May 13, 2025 | Apr 10, 2025 33 days to disclose | ↓sold | A ASHTY(ASHTY) | price pending | $15K-$50K $15,001 - $50,000 3.1% of book |
| May 13, 2025 | Apr 10, 2025 33 days to disclose | ↓sold | A ASHTY(ASHTY) | price pending | $15K-$50K $15,001 - $50,000 3.1% of book |
| Apr 11, 2025 | Mar 24, 2025 18 days to disclose | ↑bought | Common Stock (META) | Bad buy·−$1.1K-3.4% −73.0% vs S&P 500 | $15K-$50K $15,001 - $50,000 3.1% of book |
| Apr 11, 2025 | Mar 24, 2025 18 days to disclose | ↑bought | Common Stock (META) | Bad buy·−$274-3.4% −73.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Apr 11, 2025 | Mar 24, 2025 18 days to disclose | ↑bought | Common Stock (META) | Bad buy·−$274-3.4% −73.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Apr 11, 2025 | Mar 21, 2025 21 days to disclose | ↑bought | (AVGO) | Good buy·+$12.2K+152.0% +78.9% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Apr 11, 2025 | Mar 21, 2025 21 days to disclose | ↑bought | (AVGO) | Good buy·+$12.2K+152.0% +78.9% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Apr 11, 2025 | Mar 20, 2025 22 days to disclose | ↓sold | Stock (UPS) | Flat·+0.0% +31.1% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Apr 11, 2025 | Mar 20, 2025 22 days to disclose | ↓sold | Stock (UPS) | Flat·+0.0% +31.1% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Apr 11, 2025 | Mar 20, 2025 22 days to disclose | ↓sold | D DEODiageo plc Common Stock (DEO) ⚑ Consumer Defensive · Health | Flat·+0.0% +5.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Apr 11, 2025 | Mar 20, 2025 22 days to disclose | ↓sold | D DEODiageo plc Common Stock (DEO) ⚑ Consumer Defensive · Health | Flat·+0.0% +5.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Apr 11, 2025 | Mar 20, 2025 22 days to disclose | ↓sold | Stock (UPS) | Flat·+0.0% +31.1% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Apr 11, 2025 | Mar 20, 2025 22 days to disclose | ↓sold | D DEODiageo plc Common Stock (DEO) ⚑ Consumer Defensive · Health | Flat·+0.0% +5.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Apr 11, 2025 | Mar 20, 2025 22 days to disclose | ↓sold | Common Stock (CACI) | Flat·+0.0% +47.9% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Apr 11, 2025 | Mar 20, 2025 22 days to disclose | ↓sold | Common Stock (CACI) | Flat·+0.0% +47.9% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Apr 11, 2025 | Mar 20, 2025 22 days to disclose | ↓sold | Common Stock (CACI) | Flat·+0.0% +47.9% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Apr 11, 2025 | Mar 20, 2025 22 days to disclose | ↓sold | Stock (MRK) ⚑ Pharmaceutical · Health | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Apr 11, 2025 | Mar 20, 2025 22 days to disclose | ↓sold | D DHID.R. Horton, Inc. Common Stock (DHI) | Flat·+0.0% +21.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Apr 11, 2025 | Mar 20, 2025 22 days to disclose | ↓sold | D DHID.R. Horton, Inc. Common Stock (DHI) | Flat·+0.0% +21.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
| Apr 4, 2025 | Mar 21, 2025 14 days to disclose | ↓sold | Target Corporation Common Stock (TGT) | Flat·+0.0% +21.0% vs S&P 500 | $15K-$50K $15,001 - $50,000 3.1% of book |
| Apr 4, 2025 | Mar 21, 2025 14 days to disclose | ↓sold | Target Corporation Common Stock (TGT) | Flat·+0.0% +21.0% vs S&P 500 | $100K-$250K $100,001 - $250,000 16.9% of book |
| Apr 4, 2025 | Mar 3, 2025 32 days to disclose | ↑bought | Target Corporation Common Stock (TGT) Brokerage Account 1 D: Dividend Received | Good buy·+$625+7.8% −4.9% vs S&P 500 | $1K-$15K $1,001 - $15,000 0.8% of book |
Their record vs the S&P 500
58 priced trades compared to a same-direction S&P 500 benchmark.
Oversight committees · 6
Click any committee to see what it actually does, which sectors it regulates, and why each sector tag was attached. Sources cited.
Recent legislative activity · 34 bills
14 sponsored, 20 cosponsored in the 119th Congress. Color-coded by sector — yellow chips mark bills that overlap a sector this politician has actually traded in.
- To establish a rental assistance program for low-income veteran families, and for other purposes.Referred to the House Committee on Financial Services.
- Fit to Serve ActReferred to the House Committee on Armed Services.
- Ending child poverty.Referred to the House Committee on Oversight and Government Reform.
- BASICS ActReferred to the House Committee on Transportation and Infrastructure.
- Direct File Act of 2026Referred to the House Committee on Ways and Means.
- Recognizing the 75th anniversary of the American College of Obstetricians and Gynecologists and its critical role in advancing the practice of obstetrics and gynecology and the health and well-being of patients through excellence in clinical practice, education, advocacy, and research.Referred to the House Committee on Energy and Commerce.
- Pride In Mental Health Act of 2025Referred to the House Committee on Energy and Commerce.
- FORCE Act of 2025Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- PFAS–Free Procurement Act of 2025Referred to the House Committee on Oversight and Government Reform.
- Access Technology Affordability Act of 2025Referred to the House Committee on Ways and Means.
- Recognizing the week of May 3, 2026, through May 9, 2026, as "National Postpartum Awareness Week for Communities of Color".Referred to the House Committee on Energy and Commerce.
- Ensuring Justice for Camp Lejeune Victims Act of 2025Referred to the House Committee on the Judiciary.
- Stem Cell Therapeutic and Research Reauthorization Act of 2025Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
- Investing in the American Dream ActReferred to the House Committee on Small Business.
- To prohibit the Department of Homeland Security from entering into, modifying, extending, or renewing, any contract or intergovernmental service agreement to establish or operate any new immigration detention model, including the use of warehouses, modular facilities, soft-sided structures, tent systems, and processing centers.Referred to the Subcommittee on Oversight, Investigations, and Accountability.
- Women’s Heart Health Expansion Act of 2026Referred to the House Committee on Energy and Commerce.
- PFAS National Drinking Water Standard Act of 2025Referred to the House Committee on Energy and Commerce.
- DISCLOSE Act of 2026Referred to the Committee on House Administration, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- the Military PFAS Transparency Act of 2025Referred to the House Committee on Armed Services.
- School Bus Safety Act of 2025Referred to the Subcommittee on Highways and Transit.